- Home
- IMUX vs RGS Comparison
IMUX vs RGS Comparison
Compare IMUX & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- RGS
- Stock Information
- Founded
- IMUX 2016
- RGS 1922
- Country
- IMUX United States
- RGS United States
- Employees
- IMUX N/A
- RGS N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- RGS Other Consumer Services
- Sector
- IMUX Health Care
- RGS Consumer Discretionary
- Exchange
- IMUX Nasdaq
- RGS Nasdaq
- Market Cap
- IMUX 67.1M
- RGS 54.2M
- IPO Year
- IMUX N/A
- RGS 1991
- Fundamental
- Price
- IMUX $0.72
- RGS $21.30
- Analyst Decision
- IMUX Strong Buy
- RGS
- Analyst Count
- IMUX 6
- RGS 0
- Target Price
- IMUX $11.60
- RGS N/A
- AVG Volume (30 Days)
- IMUX 2.4M
- RGS 9.5K
- Earning Date
- IMUX 08-07-2025
- RGS 05-13-2025
- Dividend Yield
- IMUX N/A
- RGS N/A
- EPS Growth
- IMUX N/A
- RGS N/A
- EPS
- IMUX N/A
- RGS 41.20
- Revenue
- IMUX N/A
- RGS $199,112,000.00
- Revenue This Year
- IMUX N/A
- RGS N/A
- Revenue Next Year
- IMUX N/A
- RGS N/A
- P/E Ratio
- IMUX N/A
- RGS $0.55
- Revenue Growth
- IMUX N/A
- RGS N/A
- 52 Week Low
- IMUX $0.56
- RGS $4.50
- 52 Week High
- IMUX $2.11
- RGS $35.50
- Technical
- Relative Strength Index (RSI)
- IMUX 36.47
- RGS 48.40
- Support Level
- IMUX $0.71
- RGS $21.51
- Resistance Level
- IMUX $0.91
- RGS $23.68
- Average True Range (ATR)
- IMUX 0.07
- RGS 0.89
- MACD
- IMUX 0.00
- RGS -0.26
- Stochastic Oscillator
- IMUX 29.20
- RGS 2.30
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About RGS Regis Corporation
Regis Corp owns, franchises, and operates beauty salons throughout North America and the United Kingdom. The company's locations provide salon products and services to the mass market, including haircutting, styling, and hair coloring. The vast majority of Regis' salons are in strip malls, shopping centers, and Wal-Mart stores in North America and serve price-conscious customers. The company derives the majority of its revenue from these locations. The sale of products also contributes a relatively significant percentage of total sales. Regis also operates a smaller portfolio of premium salons across North America and the U.K. The company's majority brands include SmartStyle, Cost Cutters, and Supercuts.